COLLABORATIVE RESEARCH, LEADING INNOVATION.
The PSG is the largest non-profit clinical trial site network in North America conducting PD research. Itis composed of over 155 sites with more than 375 credentialed investigators.
It was formed in 1986, prompted by the recognition that clinical research in Parkinson disease (PD) required the participation of large numbers of research patients under the cooperative care of skilled and experienced research physicians, coordinators and allied professionals.
On behalf of the Parkinson Study Group, we would like to thank those that were able to attend the 2023 Future of Parkinson's Disease Conference in Austin, TX. We truly could not have imagined a more energetic and engaging conference. We will be updating the conference website with some post-conference details, so stay please make sure to check that out. In the meantime, enjoy this highlight real from our incredible photographer and we hope to see you all in Nashville in 2024!
Become a PSG member.
The Parkinson Study Group is continually interested in expanding our clinicaltrial sites as opportunities for new Parkinson’s Disease studies become available. Regardless of location (hospital, community-based, academic, or private practice), the PSG seeks trained Parkinson’s disease investigators who are committed to and experienced in clinical trials.
The PSG is comprised of eight (8) core committees that help execute and oversee our mission as a non-profit clinical trial organization.
The PSG Working Groups enable collaborations among investigators with related interests in PD.
The PSG is composed of over 155 sites with more than 375 credentialed investigators.